About me
Andrew Krouse has nearly two decades of Pharma leadership experience with a track record of success as the founder and CEO of venture backed companies including Cavion, Inc.(sold to Jazz Pharma in 2019), GenEp, Inc. and Slate Bio, Inc. Mr. Krouse is also an active investor in Pharma start-ups and digital healthcare companies.
Andrew has been recognized for his leadership in the industry as a CIT GAP 50 Entrepreneur in the Commonwealth of Virginia, a member of the Board of SEBIO, and is the immediate past Chairman of the Virginia Biotechnology Association.
Prior to his experience in the pharmaceutical industry, Andrew worked as an analyst for Goldman Sachs, NYC, and served as Vice President of the UVA Darden Graduate School of Business. Andrew received his M.A. from Georgetown University and his B.S. from the University of Maryland Business School. He also attended the UVA Darden Business School's TEP program.
